| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 57.34× | 57.34× | 55.57× | 66.44× | 195.57× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.34× | 2.36× | 2.54× | 2.71× | 2.84× | ||
| 1.25× | 1.25× | 1.31× | 1.39× | 1.85× | ||
| 0.96× | 0.96× | 0.99× | 1.24× | 0.70× | ||
| 0.64× | 0.64× | 0.70× | 0.89× | 0.51× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 195.57 | 66.44 | 55.57 | 57.34 | 57.34 | |
| Working Capital Turnover | 2.84 | 2.71 | 2.54 | 2.36 | 2.34 | |
| Asset Turnover | 1.85 | 1.39 | 1.31 | 1.25 | 1.25 | |
| Cash Conversion (CFO/Net Income) | 0.70 | 1.24 | 0.99 | 0.96 | 0.96 | |
| CFO/EBITDA | 0.51 | 0.89 | 0.70 | 0.64 | 0.64 |